文献速递妇科肿瘤

SENTIX试验:宫颈癌前哨淋巴结定位与术中评估的前瞻性国际多中心观察研究

Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial.
PubMed 文献 · Eur J Cancer · 2020-08-01

SENTIX是一项国际多中心前瞻性观察试验,评估早期宫颈癌前哨淋巴结活检而不行盆腔淋巴结清扫。395例预注册患者中双侧检出率91%,冰冻切片漏诊54%的阳性淋巴结,其中大转移漏诊28%、微转移漏诊90%。

要点

  • 肿瘤≤4cm的早期宫颈癌前哨淋巴结活检双侧检出率可达91%。
  • 所有前哨淋巴结均位于盆腔七个解剖区域,多数在髂血管分叉以下。
  • 术中冰冻切片仅检出约半数N1病例,不适用于术中分诊。

核心结论

  • 前哨淋巴结活检在肿瘤≤4cm的宫颈癌患者中可实现高双侧检出率。
  • 在有经验的中心,所有前哨淋巴结均位于盆腔,多数位于髂血管分叉以下。
  • 术中冰冻切片评估不可靠,仅能检出约半数N1病例。

研究设计与样本

  • 预注册IA1期伴淋巴血管间隙浸润阳性至IB2期(≤4cm,保留生育功能者≤2cm)宫颈癌患者,影像学无可疑淋巴结。
  • 要求行前哨淋巴结冰冻切片评估和病理超分期,分析395例预注册患者数据。

主要发现

  • 双侧检出率为91%(355/395),不受肿瘤大小、分期或体重指数影响。
  • 老年患者、开腹手术患者及病例数较少的中心双侧检出率较低。
  • 前哨淋巴结均位于七个盆腔解剖区域,多数前哨淋巴结和阳性前哨淋巴结位于髂总动脉分叉以下。
  • 髂分叉以上单发阳性前哨淋巴结占2%。
  • 冰冻切片漏诊54%的阳性淋巴结(pN1),包括28%的大转移和90%的微转移。

临床怎么用

  • 对肿瘤≤4cm的早期宫颈癌可考虑前哨淋巴结活检替代系统性盆腔淋巴结清扫。
  • 术中冰冻切片不能可靠识别N1,需依赖最终病理超分期决定后续处理。
  • 前哨淋巴结定位应关注髂血管分叉以下区域,但需完整评估盆腔七个解剖区域。

局限性

  • 双侧检出率在老年患者、开腹手术及病例数较少的中心较低,可能影响推广。
  • 研究为观察性设计,未报告冰冻切片与最终病理的完整一致性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: SENTIX (ENGOT-CX2/CEEGOG-CX1) is an international, multicentre, prospective observational trial evaluating sentinel lymph node (SLN) biopsy without pelvic lymph node dissection in patients with early-stage cervical cancer. We report the final preplanned analysis of the secondary end-points: SLN mapping and outcomes of intraoperative SLN pathology. METHODS: Forty-seven sites (18 countries) with experience of SLN biopsy participated in SENTIX. We preregistered patients with stage IA1/lymphovascular space invasion-positive to IB2 (4 cm or smaller or 2 cm or smaller for fertility-sparing treatment) cervical cancer without suspicious lymph nodes on imaging before surgery. SLN frozen section assessment and pathological ultrastaging were mandatory. Patients were registered postoperatively if SLN were bilaterally detected in the pelvis, and frozen sections were negative. TRIAL REGISTRATION: ClinicalTrials.gov (NCT02494063). RESULTS: We analysed data for 395 preregistered patients. Bilateral detection was achieved in 91% (355/395), and it was unaffected by tumour size, tumour stage or body mass index, but it was lower in older patients, in patients who underwent open surgery, and in sites with fewer cases. No SLN were found outside the seven anatomical pelvic regions. Most SLN and positive SLN were localised below the common iliac artery bifurcation. Single positive SLN above the iliac bifurcation were found in 2% of cases. Frozen sections failed to detect 54% of positive lymph nodes (pN1), including 28% of cases with macrometastases and 90% with micrometastases. INTERPRETATION: SLN biopsy can achieve high bilateral SLN detection in patients with tumours of 4 cm or smaller. At experienced centres, all SLN were found in the pelvis, and most were located below the iliac vessel bifurcation. SLN frozen section assessment is an unreliable tool for intraoperative triage because it only detects about half of N1 cases.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Cibula D, Kocian R, Plaikner A, et al. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial. Eur J Cancer. 2020. PMID: 32750501. doi:10.1016/j.ejca.2020.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。